Advertisement
Journal Home
Search for

Volume 67, Issue 2, Pages 144-150 (February 2010)


View previous. 5 of 22 View next.

Characteristics of never smoker lung cancer including environmental and occupational risk factors

Christelle Clément-DuchêneaCorresponding Author Informationemail address, Jean-Michel Vignaudb, Audrey Stouffletc, Odile Bertrandd, Antoine Gislarde, Luc Thibervillef, Gilles Grosdidierg, Yves Martineta, Jacques Benichouh, Pierre Hainauti, Christophe Pariscd

Received 14 November 2008; received in revised form 25 January 2009; accepted 15 April 2009. published online 22 May 2009.

Abstract 

Introduction

Clinical characteristics and risk factors of nonsmoker patients with lung cancer are still debated.

Aim and methods

The aim of this work is to describe the characteristics of never smoker patients with lung cancer, focusing on occupational and environmental exposures, Data collected were: age, gender, histological types, methods of diagnosis, TNM staging, smoking, and occupational data. Statistical analysis included descriptive analyses, Pearson's chi-square or nonparametric tests, and logistic regressions.

Results

All lung cancers diagnosed between January 1, 1997 and December 31, 2006, representing 1493 cases were included. Lung adenocarcinoma (ADC) [Odds Ratio (OR)=2.5 (1.5–4.3), p<0.0001] as well as clinical stage I cases at diagnosis [OR=2.4 (1.3–4.3)] were most frequent in nonsmokers relative to ever smokers. Comparison of clinical features among male and female nonsmoker patients did not reveal significant differences. Conversely, strong differences appeared when comparing environmental tobacco smoke (ETS) and occupational exposures in nonsmoker women vs men: ETS exposure (78.6% nonsmoker women vs 21.4% nonsmoker men, p<0.0001), occupational exposure (9.4% vs 48.6%, p<0.0005). Noteworthy, a sizeable number of nonsmoker male (40.0%), and nonsmoker female (31.2%) patients had no known exposure to major lung carcinogens.

Conclusions

Main risk factors (ETS and occupational exposure) may only explain some cases.

a Respiratory Diseases Department, University Hospital, Vandoeuvre-Les-Nancy, France

b Pathology Department, University Hospital, Nancy, France

c Inserm U954, Vandoeuvre-Les-Nancy, France

d Occupational Diseases Department, University Hospital, Nancy, France

e Occupational Diseases Department, University Hospital, Rouen, France

f Pneumology Clinic, University Hospital, EA 4108 LITIS-QUANTIF Laboratory, Rouen, France

g Thoracic Surgery Department, University Hospital, Nancy, France

h Biostatistics Department, University Hospital, Rouen, France

i Cluster of Molecular Carcinogenesis Department, International Agency for Research on Cancer, Lyon, France

Corresponding Author InformationCorresponding author at: Service de Pneumologie, Hôpital de Brabois, CHU de Nancy, 54511 Vandoeuvre-lès-Nancy, France. Tel.: +33 3 83 15 33 93; fax: +33 3 83 15 34 06.

PII: S0169-5002(09)00216-5

doi:10.1016/j.lungcan.2009.04.005


View previous. 5 of 22 View next.